Representation matters: inclusivity in clinical trials

Because disease outcomes and responses to treatment can vary across populations, clinical research must include patients who are racially, ethnically and gender representative of those who experience health conditions.

Scientists are pioneering new ways of achieving inclusive and diverse clinical trials, which can lead to a better understanding of disease biology and ultimately improved treatment and care for women and other populations that have historically been excluded from research in the past.

Tune in to hear Maria Wilson, Executive Director, Project Team Leader, Genentech sits down with Nicole Richie, Global Head of Health Equity and Population Science, and Jenn Pangilinan, Vice President, Genentech Research and Early Development (gRED) Clinical Operations, discuss the nuances of human biological difference and how we can take a more thoughtful approach to diversity in clinical trials.

“Black women are three times more likely to die than white women. And that’s through data information from the clinical setting that we learned that information. If we learn these new things from our drug discovery and scientific discovery, then, perhaps we could be developing new medicines for these patient populations.”
Jenn Pangilinan
Vice President, Genentech Research and Early Development Clinical Operations
Part of the podcast
A closer look at more inclusive research
View series overview
Published undefined

Stories of X

See all stories